Dan Ross
Partner @ Health Catalyst Capital
New York, United States
Dan Ross is a Series A investor at Health Catalyst Capital in New York focused on SaaS and FinTech. Daniel R. Ross is a business executive and entrepreneur active in tech-enabled enterprises in the healthcare services sector.Most recently, Dan founded ArcWell Medical, a New York-based provider of post-acute and long-term care physician services, which he sold to IPC Healthcare (NASDAQ:IPCM) in 2015. Before founding ArcWell, Dan in 1996co-founded Allegiance Health, a physician network providing medical claims-handling services to the insurance industry. After leading Allegiance Health for eight years, in 2004 Dan and his partners sold that organization to a New Jersey based public company, where he served for two years as Executive Vice-President, managing a division providing similar services nationally.Before co-founding Allegiance Health, Dan spent 13 years in the investment banking industry, largely at Salomon Brothers (now part of Citigroup). Prior to his investment banking career, Dan practiced law with Cravath, Swaine & Moore in New York City.Dan is currently a member of the Board of Directors of Open Door Medical Center, a provider of primary health care and human services to underserved individuals in Westchester County, NY, and is a volunteer advisor of recent college graduates through the Harvard Alumni Association. He has recently retired as a member of the board of directors of Summit Preparatory School in Kalispell, Montana, and is a former member of the North London Board of the Prince’s Youth Business Trust, an organization providing mentorship for young entrepreneurs in the United Kingdom.Dan graduated from The University of Virginia School of Law, where he was an editor of the Virginia Law Review, and Harvard University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Dan Ross invests in
Stages Dan Ross invests in
Countries Dan Ross invests in
Investment Focus
Industry
- SaaS 1 (100%)
- FinTech 1 (100%)
- mHealth 1 (100%)
- Consumer 1 (100%)
- Payments 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
HealthExpense is streamlining consumer-to-provider payments in healthcare with its pioneering, cloud-based technology/data platform. The HIPAA-certified HealthExpense platform powers market-leading track & pay, messaging, and transparency products for health plans, third party administrators and financial institutions.Consumers usecomplex, changing, and often confusing processes to pay $300+ Billion per year out-of-pocket to Healthcare Providers. Many patients are asked to take on more financial responsibility for their healthcare every year. Health plan administrators engage with consumers to manage compliant reimbursement for IRS-regulated spending every year. HealthExpense data products generate immediate cost savings, help clients differentiate themselves during this payment/reimbursement market transition, and create new data-driven visibility in payments, consumer engagement, and provider choices for administrators and patients alike.In 2014 HealthExpense’s technology was integrated with partners who serve more than 32 million consumers. Its track & pay product was launched with those partners and the number of members under management has grown dramatically since. | $6.3M / Series A / Jan 01, 2015 |
Co-Investors
About Health Catalyst Capital
Health Catalyst Capital Management is a venture capital fund investing in high growth US- based Healthcare IT businesses focused in a few key themes, each with potential to achieve $1 billion enterprise value in new or disrupted markets globally.
Health Catalyst Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dan Ross
Partner
|
|||
|
Bryan Carey
Operating Partner
|
|||
|
Charles Boorady
Managing Partner
|
|||
|
Nikhil Hanmantgad
Principal
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dan Ross invest in?
Dan Ross invests primarily in SaaS, FinTech and mHealth startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dan Ross last invest?
The most recent investment recorded for Dan Ross closed in Jan 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!